Article

Screening and identification of gene expression in large cohorts of clinical lung cancer samples unveils the major involvement of EZH2 and SOX2

2024-09-18

Abstract excerpt

Lung adenocarcinoma (LUAD), the primary subtype of Non-Small Cell Lung Cancer (NSCLC), accounts for 80% to 85% of cases. Due to suboptimal screening method, LUAD is often detected in late stage, leading to aggressive progression and poor outcomes. Therefore, early disease prognosis for the LUAD is high priority. In order to identify early detection biomarkers, we conducted a meta-analysis of mRNA expression TCGA a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fd245387-c045-5cb8-81aa-79d94d3716cb
DOI: 10.1101/2024.09.17.613500

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Screening and identification of gene expression in large cohorts of clinical lung cancer samples unveils the major involvement of EZH2 and SOX2DOI 10.1101/2024.09.17.613500Read

EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltratesSemantic proximity Read

Identification of differentially expressed genes in non-small cell lung cancerSemantic proximity Read

Differential gene expression analysis and machine learning identified structural, TFs, cytokine and glycoproteins, including SOX2, TOP2A, SPP1, COL1A1, and TIMP1 as potential drivers of lung cancerSemantic proximity Read

Utilising multi-modal data-driven network analysis to identify monotherapy and combinational therapy targets in SOX2-dependent squamous cell lung cancerSemantic proximity Read

Comprehensive pan-cancer analysis identifies H2AFX associated with poor prognosis in lung adenocarcinomaSemantic proximity Read

Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer.Semantic proximity Read

Clinicopathological significance and prognostic role of EZH2 expression in non-small cell lung cancerSemantic proximity Read

Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.Semantic proximity Read

Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysisSemantic proximity Read

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.Semantic proximity Read

Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic CancerSemantic proximity Read

BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous cell carcinomaSemantic proximity Read